CSIMarket
 
Nevro Corp   (NYSE: NVRO)
 
Price: $5.8400 $0.00 0.000%
Day's High: $5.86 Week Perf: 0.00
Day's Low: $ 5.84 30 Day Perf: 1.92 %
Volume (M): 753,600 52 Wk High: $ 0.00
Volume (M$): $ 4,401 52 Wk Avg: $0.00
Open: $5.84 52 Wk Low: $0.00



 Market Capitalization (Millions $) 217
 Shares Outstanding (Millions) 37
 Employees 1,215
 Revenues (TTM) (Millions $) 408
 Net Income (TTM) (Millions $) -113
 Cash Flow (TTM) (Millions $) -10
 Capital Exp. (TTM) (Millions $) 10

Business Description


Nevro Corp is a medical technology company that specializes in the development and commercialization of innovative spinal cord stimulation therapies for patients suffering from chronic pain. The company was founded in 2006 and is headquartered in Redwood City, California. Nevro's flagship product is the Senza system, which uses high-frequency spinal cord stimulation to provide long-lasting pain relief to patients.

The Senza system works by delivering electrical pulses to the nerve fibers in the spinal cord, which disrupt the pain signals that are being sent from the affected area of the body to the brain. This results in significant and sustained relief from chronic pain, without the need for opioids or other potentially addictive medications. The Senza system is designed to be highly customizable to the individual patient's needs, with a range of different stimulation options and programming settings available.

Nevro has a strong commitment to research and development, with a dedicated team working to continually improve the Senza system and explore new approaches to pain management. The company has invested heavily in large-scale clinical trials to demonstrate the safety and effectiveness of its technology, and has published numerous peer-reviewed studies in leading medical journals.

In addition to the Senza system, Nevro offers a range of related products and services, including training and support for healthcare providers, patient education resources, and clinical research collaboration opportunities. The company has a global presence, with operations in Europe, Asia-Pacific, and North America, and is actively expanding its reach into new markets and treatment areas.

Overall, Nevro Corp is a pioneering medical technology company that is making a major impact in the field of pain management. With its innovative spinal cord stimulation technology, commitment to research and development, and global reach, Nevro is a leading player in this fast-growing market.


   Company Address: 1800 Bridge Parkway Redwood City 94065 CA
   Company Phone Number: 251-0005   Stock Exchange / Ticker: NYSE NVRO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BSX   -7.83%    
INSP        16.03% 
MDT   -2.35%    
SYK   -12.49%    
TCMD        0.95% 
ZYXI   -52.62%    
• View Complete Report
   



Stocks on the Move

Market Sentiment Sours Decoding Nevro Corps Stock Sell-Off Amid Financial Struggles,

Published Thu, Aug 8 2024 3:19 PM UTC

In recent trading sessions, Nevro Corp (NYSE: NVRO) has experienced a noticeable decline, trailing behind broader market performance. This sell-off can be attributed to a confluence of analyst downgrades, disappointing financial results, and strategic uncertainties that raise concerns among investors. As Nevro navigates this turbulent landscape, understanding the undercurren...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.53
Price to Sales (Expected) -
Price to Book 0.94
PEG (TTM) -

Financial Strength Current
Quick Ratio 2.84
Working Capital Ratio 4.62
Leverage Ratio (MRQ) 1.4
Total Debt to Equity 0.98
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -3.07 $
Revenues (TTM) 10.99 $
Cash Flow (TTM) -
Cash 7.89 $
Book Value 6.23 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 335,414
Net Income per Employee (TTM) -93,365
Receivable Turnover Ratio (TTM) 5.55
Inventory Turnover Ratio (TTM) 1.17
Asset Turnover Ratio (TTM) 0.71

Profitability Ratios Current
Gross Margin (MRQ) 62.24 %
Operating Margin (MRQ) -48.54 %
Net Margin (MRQ) -50.14 %
Net Cash Flow Margin (MRQ) 21.21 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.